CMSHealth Care FinanceMedicare - GeneralMedicare AdvantagePart D/Prescription Drugs

Why higher Medicare Advantage utilization wasn’t reflected in 2025 rates

(By Jakob Emerson for Becker’s Hospital Review)

CMS has finalized a slight decrease in Medicare Advantage benchmark payments for 2025, despite large insurers reporting rising costs and utilization among MA members.

“We are aware of numerous reports from MA organizations and stakeholders stating that MA organizations’ trends, especially for fourth quarter 2023, are inconsistent with [Medicare FFS cost trends],” CMS wrote April 1. “We are not aware of all of the specific drivers accounting for the experience of these MA organizations. We have reviewed incomplete fourth quarter 2023 Medicare FFS incurred experience and it is consistent with our projections.” Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.